Big Pharma’s Latest Breakthrough: Choosing Its First Female CEO
- Emma Walmsley to be the only woman leading a top-25 drugmaker
- “I’ve never primarily defined myself by my gender,” she says
Emma Walmsley
Source: GlaxoSmithKlineThis article is for subscribers only.
GlaxoSmithKline Plc’s new chief executive looks a lot like other bosses at large pharmaceutical companies: a graduate of Oxford, white, with worldwide experience managing thousands of employees. There is, though, one big difference: She’s not a man.
Emma Walmsley will lead the British drugmaker starting in March, breaking the gender barrier at the world’s top 25 drugmakers and highlighting the dearth of female leadership among Europe’s biggest companies.